Modeling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection

Modeling HCV RNA decline kinetics under therapy has proven useful for characterizing treatment effectiveness. Here we model HCV viral kinetics (VK) in 72 patients given a combination of danoprevir, a protease inhibitor and mericitabine, a nucleoside polymerase inhibitor for 14 days in the INFORM-1 t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antivir Ther
Asıl Yazarlar: Canini, Laetitia, Guedj, Jeremie, Chatterjee, Anushree, Lemenuel-Diot, Annabelle, Smith, Patrick F, Perelson, Alan S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862948/
https://ncbi.nlm.nih.gov/pubmed/26555159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3006
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller